Drug Shortage Report for DILAUDID
Report ID | 12597 |
Drug Identification Number | 00627100 |
Brand name | DILAUDID |
Common or Proper name | Hydromorphone Hydrochloride, 2mg/mL |
Company Name | PURDUE PHARMA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
Strength(s) | 2MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 25 x 1 mL ampoules |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2017-06-12 |
Actual start date | 2017-06-12 |
Estimated end date | 2017-12-31 |
Actual end date | 2017-12-31 |
Shortage status | Resolved |
Updated date | 2020-03-23 |
Company comments | Inventory constraints |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-06-12 | English | Compare |
v2 | 2017-06-12 | French | Compare |
v3 | 2017-06-12 | English | Compare |
v4 | 2017-06-12 | French | Compare |
v5 | 2017-06-13 | English | Compare |
v6 | 2017-06-13 | English | Compare |
v7 | 2017-06-13 | French | Compare |
v8 | 2020-03-23 | English | Compare |
v9 | 2020-03-23 | French | Compare |
Showing 1 to 9 of 9